Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
219.7 USD | +0.37% | +1.66% | -15.09% |
09:00am | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
08/05 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.09% | 31.99B | |
-3.35% | 88.91B | |
+4.08% | 41.25B | |
+52.15% | 24.73B | |
-15.13% | 15.54B | |
-8.63% | 12.05B | |
-40.39% | 12.07B | |
+6.22% | 8.84B | |
-5.50% | 8.3B | |
-6.45% | 7.07B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- UBS Cuts Biogen Price Target to $250 From $276, Maintains Neutral Rating